• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

TIANEPTINE Drug Record

  • Summary
  • Interactions
  • Claims
  • TIANEPTINE chembl:CHEMBL1289110

    Alternate Names:

    TIANEPTINE
    7-[(3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO[C,F][1,2]THIAZEPIN-11-YL)-AMINO]HEPTANOIC ACID S,S-DIOXIDE
    (±)-TIANEPTINE
    STABLON®
    drugbank:09289
    chemidplus:72797-41-2
    chemidplus:66981-73-5
    chembl:CHEMBL1289110
    pubchem.compound:68870

    Drug Info:

    Drug Type small molecule
    Drug Groups investigational
    Drug Categories agents causing muscle toxicity
    Drug Categories agents that produce hypertension
    Drug Categories agents that reduce seizure threshold
    Drug Categories analgesics
    Drug Categories antidepressive agents
    Drug Categories antidepressive agents, tricyclic
    Drug Categories azepines
    Drug Categories central nervous system agents
    Drug Categories central nervous system depressants
    Drug Categories cytochrome p-450 cyp3a substrates
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index
    Drug Categories cytochrome p-450 substrates
    Drug Categories narrow therapeutic index drugs
    Drug Categories nervous system
    Drug Categories neurotoxic agents
    Drug Categories psychoanaleptics
    Drug Categories psychotropic drugs
    Drug Categories serotonergic drugs shown to increase risk of serotonin syndrome
    Drug Categories serotonin agents
    Drug Categories serotonin modulators
    Drug Categories sulfur compounds
    Drug Categories thiepins
    (0 More Sources)

    Publications:

    Gassaway MM et al., 2014, The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist., Transl Psychiatry
    Samuels BA et al., 2017, The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor., Neuropsychopharmacology
    McEwen BS et al., 2010, The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation., Mol Psychiatry
    Dziedzicka-Wasylewska M et al., 2002, Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors., Behav Pharmacol
    Datla KP et al., 1993, Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine., Neuropharmacology
    Sonawalla S et al., 2003, Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India., J Indian Med Assoc
  • TIANEPTINE   GRIA1

    Interaction Score: 0.86

    Interaction Types & Directionality:
    modulator

    Interaction Info:

    PMIDs:
    19704408


    Sources:
    DrugBank

  • TIANEPTINE   OPRM1

    Interaction Score: 0.39

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    25026323 28303899


    Sources:
    PharmGKB DrugBank

  • TIANEPTINE   HTR1A

    Interaction Score: 0.28

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:

    PMIDs:
    7694170 12841497


    Sources:
    DrugBank

  • TIANEPTINE   DRD3

    Interaction Score: 0.28

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    11981225


    Sources:
    DrugBank

  • DrugBank: DB09289

    • Version: 5.1.7

    Alternate Names:
    TIANEPTINE DrugBank Drug Name
    72797-41-2 CAS Number
    Coaxil Drug Brand

    Drug Info:
    Drug Type small molecule
    Drug Groups investigational
    Drug Categories agents causing muscle toxicity

    Publications:
    Dziedzicka-Wasylewska M et al., 2002, Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors., Behav Pharmacol
    Datla KP et al., 1993, Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine., Neuropharmacology
    Sonawalla S et al., 2003, Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India., J Indian Med Assoc

  • TTD: Tianeptine

    • Version: 2020.06.01

    Alternate Names:
    D06CVT TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1289110

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • PharmGKB: tianeptine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21